Skip to main content
. 2021 Oct 4;9(10):e002505. doi: 10.1136/jitc-2021-002505

Figure 2.

Figure 2

Safety profile in the OPERA trial.AEs, adverse events; SAEs, serious AEs, CRP, C-reactive protein; INR, international normalized ratio.